Atara

Atara Bio-therapeutics, Inc., a bio-pharmaceutical company, announced the pricing of its underwritten public offering of 3,461,538 shares of its common stock at a public offering price of $52.00 per share. The offering is expected to close on July 15, 2015, subject to customary closing conditions. The Gross proceeds would be around $180 million. Goldman, Sachs & […]